Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 51 PAGES: 52

Hologic, Inc. (Hologic) is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems exclusively serving the healthcare needs of women. The company is also a leading developer of innovative imaging technology for digital radiography and breast imaging applications. Hologic's core business units are concentrated on mammography and breast biopsy, osteoporosis assessment, mini C-arm and extremity MRI imaging for orthopedic procedures. The company operates across North America, Europe, Central America, Australia and Asia.

More Info
									           Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME713FSA                                                                                             Publication Date: JAN 2013

          35 Crosby Drive                                    Phone              +1 781 9997300                  Revenue           2,002.7 (million USD)
          Bedford, MA                                        Fax                +1 302 6365454                  Net Profit        -73.63 (million USD)
          01730                                              Website            www.hologic.com                 Employees         6,157
          United States                                      Exchange           HOLX [NASDAQ]                   Industry          Medical Equipment

       Company Overview
       Hologic, Inc. (Hologic) is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems
       exclusively serving the healthcare needs of women. The company is also a leading developer of innovative imaging technology
       for digital radiography and breast imaging applications. Hologic's core business units are concentrated on mammography and
       breast biopsy, osteoporosis assessment, mini C-arm and extremity MRI imaging for orthopedic procedures. The company
       operates across North America, Europe, Central America, Australia and Asia.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Hologic, Inc., SWOT Analysis
         Glenn P. Muir                       Chief Financial Officer                  Strengths                              Weaknesses
         Robert A. Cascella                  Chief Executive Officer
                                                                                      Strong Sales and Distribution          Litigation
         David R. LaVance, Jr.               Chairman                                 Network
                                                                                                                             Lack of Geographical
         Nancy L. Leaming                    Director
                                                                                      Focused Research and                   Diversification
         Lawrence M. Levy                    Director                                 Development Capability
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                          Threats
       Share Data
         Hologic, Inc.                                                                Strategic Acquisitions                 Stringent Government
                                                                                                                             Regulations
        Share Price (USD) as on 15-Jan-                                22.73          Product Approvals
        2013                                                                                                                 Highly Competitive Market
        EPS (USD)                                                       -0.28
        Market Cap (million USD)                                       6,064         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                10,539
        Shares Outstanding (million)                                     267
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Jan 09, 2013         Hologic Announces New Clinical Study Results
                                                                                                           Demonstrate Efficacy Of 3D Mammography In
                                                                                                           Combination With 2D Breast Exam In Cancer
                                                                                                           Detection Over 2D Breast Exam Alone
                                                                                      Dec 28, 2012         K-V Pharma Receives US Bankruptcy Court
                                                                                                           Approval Of Hologic Settlement
                                                                                      Dec 05, 2012         K-V Pharma Enters Into $60m Settlement
                                                                                                           Agreement With Hologic
                                                                                      Nov 19, 2012         Hologic To Showcase 3D Mammography And
       Source: Annual Report, Company Website, Primary and Secondary
                                                                                                           Other Advanced Imaging Technologies At
       Research, GlobalData                                                                                RSNA 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis                                                                      Reference Code: GDME713FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Hologic, Inc. - Key Facts..................................................................................................................................................................... 5
       Hologic, Inc. - Key Employees............................................................................................................................................................ 6
       Hologic, Inc. - Key Employee Biographies.......................................................................................................................................... 7
       Hologic, Inc. - Major Products and Services ....................................................................................................................................... 8
       Hologic, Inc. - Medical Equipment Pipeline Products Data ............................................................................................................... 11
          Hologic, Inc. Pipeline Products by Equipment Type ..................................................................................................................... 11
          Hologic, Inc. Pipeline Products by Development Stage ................................................................................................................ 13
       Hologic, Inc. - History ....................................................................................................................................................................... 15
       Hologic, Inc. - Company Statement .................................................................................................................................................. 18
       Hologic, Inc. - Locations And Subsidiaries ....................................................................................................................................... 19
          Head Office ................................................................................................................................................................................... 19
          Other Locations & Subsidiaries ..................................................................................................................................................... 19
       Hologic, Inc. - Key Manufacturing Facilities ...................................................................................................................................... 21
       Section 2 – Company Analysis ......................................................................................................................................................... 22
       Hologic, Inc. - Business Description ................................................................................................................................................. 22
          Business Description - Breast Health ........................................................................................................................................... 22
             Breast Health - Overview .......................................................................................................................................................... 22
             Breast Health - Financials ......................................................................................................................................................... 22
             Breast Health - Capital Expenditure .......................................................................................................................................... 22
             Breast Health - Technology ....................................................................................................................................................... 23
          Business Description - Diagnostics ............................................................................................................................................... 23
             Diagnostics - Overview.............................................................................................................................................................. 23
             Diagnostics - Financials ............................................................................................................................................................ 23
             Diagnostics - Capital Expenditure ............................................................................................................................................. 23
             Diagnostics - Market View ......................................................................................................................................................... 23
             Diagnostics - Technology .......................................................................................................................................................... 23
          Business Description - GYN Surgical............................................................................................................................................ 23
             GYN Surgical - Overview .......................................................................................................................................................... 23
             GYN Surgical - Financials ......................................................................................................................................................... 23
             GYN Surgical - Capital Expenditure .......................................................................................................................................... 24
             GYN Surgical - Technology ....................................................................................................................................................... 24
          Business Description - Skeletal Health ......................................................................................................................................... 24
             Skeletal Health - Overview ........................................................................................................................................................ 24
             Skeletal Health - Financials ....................................................................................................................................................... 24
             Skeletal Health - Capital Expenditure ........................................................................................................................................ 24
             Skeletal Health - Market View ................................................................................................................................................... 24
             Skeletal Health - Technology .................................................................................................................................................... 24
       Hologic, Inc. - Corporate Strategy .................................................................................................................................................... 25
       Hologic, Inc. - SWOT Analysis ......................................................................................................................................................... 26
          SWOT Analysis - Overview........................................................................................................................................................... 26
          Hologic, Inc. - Strengths................................................................................................................................................................ 26


Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis                                                                                                      Reference Code: GDME713FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Strength - Strong Sales and Distribution Network ..................................................................................................................... 26
             Strength - Focused Research and Development Capability ...................................................................................................... 26
             Strength - Diversified Product Portfolio ..................................................................................................................................... 26
          Hologic, Inc. - Weaknesses .......................................................................................................................................................... 27
             Weakness - Litigation ................................................................................................................................................................ 27
             Weakness - Lack of Geographical Diversification ..................................................................................................................... 27
             Weakness - Declining Cash Reserves ...................................................................................................................................... 27
          Hologic, In
								
To top